What is Eagle Genomics?
Eagle Genomics operates at the critical intersection of biology, data science, and bioinformatics. By leveraging its award-winning AI-augmented knowledge discovery platform, e[datascientist], the company enables organizations to transform multi-dimensional data into high-value insights with unprecedented speed. This platform is instrumental in accelerating the generative economy, allowing enterprises in the Food and Nutrition, Beauty and Personal Care, AgBio, and BioPharma sectors to streamline their innovation workflows. From hypothesis generation to product claims, Eagle Genomics provides the digital infrastructure necessary for science-led innovation, effectively reducing the time-to-market for sustainable and next-generation products.
How much funding has Eagle Genomics raised?
Eagle Genomics has raised a total of $16.3M across 6 funding rounds:
Unspecified
$918K
Unspecified
$661K
Unspecified
$1.3M
Unspecified
$1M
Unspecified
$3.5M
Unspecified
$9M
Unspecified (2013): $918K with participation from Cambridge Capital Group, Midven, and London Business Angels
Unspecified (2013): $661K led by Angel CoFund and London Business Angels
Unspecified (2016): $1.3M supported by Newable Private Investing and Angels in MedCity
Unspecified (2018): $1M featuring UK Innovation & Science Seed Fund
Unspecified (2019): $3.5M backed by Environmental Technologies Fund, Newable Private Investing, and UK Innovation & Science Seed Fund
Unspecified (2020): $9M with participation from ETF Partners LLP
Key Investors in Eagle Genomics
ETF Partners
A venture capital firm focused on sustainability through innovation, supporting talented entrepreneurs with capital sourced from institutional investors and global corporations.
Cambridge Capital Group
A prominent business angel network with 25 years of experience investing in high-tech startups across the UK's Golden Triangle, specializing in medtech and AI.
Midven
A Birmingham-based venture capital firm that provides hands-on support and capital to early-stage businesses with high growth potential in the West Midlands.
What's next for Eagle Genomics?
With the support of its latest capital injection, Eagle Genomics is poised to deepen its strategic influence within the microbiome research landscape. The company's roadmap focuses on enhancing the scalability of its knowledge discovery platform to meet the growing demand for data-driven product development. By fostering continued relationships with leading scientific establishments and leveraging its position within the UK's Microbiome Strategic Roadmap, Eagle Genomics is set to solidify its role as a foundational partner for global corporations. Future growth will likely center on expanding the platform's analytical capabilities and broadening its reach into new vertical markets that require sophisticated, AI-driven biological data interpretation.
See full Eagle Genomics company page
